XERS - Xeris Biopharma Holdings Inc. (XERS) CEO Paul Edick on Q4 2021 Results - Earnings Call Transcript
Xeris Biopharma Holdings, Inc. (XERS) Q4 2021 Earnings Conference Call March 10, 2022, 08:30 AM ET Company Participants Allison Wey - SVP, IR and Corporate Communications Paul Edick - Chairman and CEO Steve Pieper - CFO Conference Call Participants Roanna Ruiz - SVB Leerink Vamil Divan - Mizuho Securities David Amsellem - Piper Sandler Presentation Operator Hello everyone. And welcome to the Xeris Biopharma Fourth Quarter 2021 Financial Results Conference Call and Webcast. My name is Seth and I will be the operator for your call today. [Operator Instructions]. I will now hand the floor over to, Allison Wey, to begin. Please go ahead. Allison Wey Thank you. Good morning. And welcome to Xeris Biopharma's fourth quarter 2021 financial results and corporate update conference call and webcast. A press release with the company's fourth quarter and full year 2021 financial results was issued earlier this morning and can be found
For further details see:
Xeris Biopharma Holdings, Inc. (XERS) CEO Paul Edick on Q4 2021 Results - Earnings Call Transcript